Evidence map›Paper›PMID 33883205›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2021

CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions.

Ha Thi Vo, Bruno Charpiat, Sebastien Chanoine, Michel Juste, Renaud Roubille, François-Xavier Rose, Ornella Conort, Benoît Allenet, Pierrick Bedouch, Working Group “Valorization of Pharmacist Interventions” of the French Society of Clinical Pharmacy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Multidisciplinary perspectives on roles of hospital pharmacists in tertiary settings: a qualitative study.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ha Thi VoFaculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh, Vietnam havothipharma@gmail.com.ORCID 0000-0001-6170-0957
Bruno CharpiatThEMAS (Techniques for Evaluation and Modeling of Health Actions) TIMC-IMAG (Techniques for Biomedical Engineering and Complexity Management - Informatics, Mathematics and Applications) UMR CNRS (National Institute of Sciences of the Universe - Research Unit 5525), Grenoble Alpes University, Grenoble, France.
Sebastien ChanoineGrenoble School of Pharmacy, Univ Grenoble Alpes, Grenoble, France.
Michel JusteCentre Hospitalier Auban-Moët, Pharmacie, Epernay, France.
Renaud RoubilleCentre Hospitalier Lucien Hussel, Pharmacie, Vienne, France.
François-Xavier RosePharmacie, EPSM Morbihan, Saint-Ave, Bretagne, France.
Ornella ConortPharmacy hôpital Cochin, Assistance Publique - Hopitaux de Paris, Paris, France.
Benoît AllenetThEMAS (Techniques for Evaluation and Modeling of Health Actions) TIMC-IMAG (Techniques for Biomedical Engineering and Complexity Management - Informatics, Mathematics and Applications) UMR CNRS (National Institute of Sciences of the Universe - Research Unit 5525), Grenoble Alpes University, Grenoble, France.
Pierrick BedouchThEMAS (Techniques for Evaluation and Modeling of Health Actions) TIMC-IMAG (Techniques for Biomedical Engineering and Complexity Management - Informatics, Mathematics and Applications) UMR CNRS (National Institute of Sciences of the Universe - Research Unit 5525), Grenoble Alpes University, Grenoble, France.
Working Group “Valorization of Pharmacist Interventions” of the French Society of Clinical Pharmacy

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesClinical pharmacists' interventions (PIs) are an important element in ensuring good pharmaceutical care. We aimed to develop and validate a comprehensive multidimensional tool for assessing the potential impact of PIs for daily practice of medication review.

methodsExperts of the French Society of Clinical Pharmacy (SFPC) developed the CLinical, Economic and Organisational (CLEO) tool, consisting of three independent dimensions concerning clinical, economic and organisational impact. They were asked to analyse 30 scenarios of PIs, and re-rated 10 PIs with a washout of 1 month (internal validation). Then, seven external experts not involved in the development of the tool rated 60 scenarios collected when using the CLEO in daily practice. Inter- and intra-rater reliabilities were determined by calculation of the intra-class correlation (ICC

resultsFor internal reliability, the inter-rater reliability for the CLEO tool was good for clinical dimensions (ICC

conclusionsCLEO is a comprehensive tool assessing clinical, economic and organisational impacts of PIs which has been developed, validated and was reliable and feasible for use in routine clinical practice.

Indexed as

PharmacistsPharmacy Service, HospitalHumansReproducibility of ResultsSurveys and Questionnairesdocumentationhospitalpharmacy serviceprofessional competencequality of health caresafety

Identifiers

PMID33883205
PMCPMC8239266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.